SCHEMBL12200059

SCHEMBL12200059

C#CCN(C)C(CC)Cc1ccccc1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 11/20 0.74
MAOA P21397 7/20 0.66
CYP1A2 P05177 3/20 0.66
TSHR P16473 3/20 0.66
CYP2D6 P10635 2/20 0.66
ADRA2B P18089 2/20 0.66
ADRA2C P18825 2/20 0.66
ADRA1A P35348 2/20 0.66
OPRK1 P41145 2/20 0.66
ADRA2A P08913 1/20 0.66
SNCA P37840 1/20 0.66
PKM P14618 1/20 0.66
MAPK1 P28482 1/20 0.64
KDM4E B2RXH2 1/20 0.64
LMNA P02545 2/20 0.50
CYP3A4 P08684 2/20 0.50
USP2 O75604 1/20 0.50
PYCR1 P32322 1/20 0.50
ALDH1A1 P00352 1/20 0.49
BLM P54132 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12171067 1.00 MAOB (0.74) MAOBMAOACYP1A2TSHRCYP2D6
SCHEMBL2477758 0.85 MAOB (1.00) MAOBMAOACYP1A2TSHRCYP2D6
SCHEMBL18995801 0.85 MAOB (0.72) MAOBMAOACYP1A2TSHRCYP2D6
SCHEMBL2475876 0.85 MAOB (0.72) MAOBMAOACYP1A2TSHRCYP2D6
SCHEMBL2471463 0.85 MAOB (1.00) MAOBMAOACYP1A2TSHRCYP2D6
SCHEMBL2616094 0.85 MAOB (1.00) MAOBMAOACYP1A2TSHRCYP2D6
SCHEMBL693555 0.85 MAOB (0.72) MAOBMAOACYP1A2TSHRCYP2D6
SCHEMBL694164 0.85 MAOB (0.72) MAOBMAOACYP1A2TSHRCYP2D6
SCHEMBL13154518 0.85 MAOB (1.00) MAOBMAOACYP1A2TSHRCYP2D6
SCHEMBL2127310 0.85 MAOB (0.72) MAOBMAOACYP1A2TSHRCYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2374779-A1 Compounds for use in imaging, diagnosing and/or treatment of diseases of the central nervous system or of tumors Bayer Pharma Aktiengesellschaft (DE) 2011-10-12 EP disclosed